[Federal Register Volume 89, Number 201 (Thursday, October 17, 2024)]
[Notices]
[Pages 83688-83689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23885]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Advisory Council for the Elimination of
Tuberculosis
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Advisory Council for the Elimination of
Tuberculosis (ACET). This meeting is open to the public, limited only
by the number of audio and web conference lines (1,000 lines are
available). Time will be available for public comment (registration is
required to provide oral comment; see the Oral Public Comment section
below).
DATES: The meeting will be held on December 3, 2024, from 9:30 a.m. to
4:30 p.m., EST, and December 4, 2024, from 10 a.m. to 12 p.m., EST.
Written comments must be submitted by November 26, 2024.
Registration to make oral comments must also be submitted by November
26, 2024.
ADDRESSES: The public meeting will be held virtually through Zoom.
Registration in advance is required to attend. Please visit https://cdc.zoomgov.com/webinar/register/WN_1bRtm_1MRoiz83dFlQoHQQ to register.
This registration for virtual attendance will remain open through the
meeting. Prior to the meeting, each individual registrant will receive
a registration confirmation along with an access link to the virtual
meeting location.
FOR FURTHER INFORMATION CONTACT: Marah Condit, M.S., Committee
Management Lead, Office of Policy, Planning, and Partnerships, National
Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US8-6,
Atlanta, Georgia 30329-4027. Telephone: (404) 639-3423; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Council for the Elimination of Tuberculosis
is charged with providing advice and recommendations regarding the
elimination of tuberculosis (TB) to the Secretary of Health and Human
Services, the Assistant Secretary for Health, and the Director, Centers
for Disease Control and Prevention (CDC). Specifically, the Council
makes recommendations regarding policies, strategies, objectives, and
priorities; addresses the development and application of new
technologies; provides guidance and review on CDC's Tuberculosis
Prevention Research portfolio and program priorities; and reviews the
extent to which progress has been made toward eliminating TB.
Matters to be Considered: The agenda will include discussions on:
(1) CDC's National Center for HIV, Viral Hepatitis, STD, and TB
Prevention Update; (2) CDC's Division of Tuberculosis Elimination
Update; (3) TB in New Arrivals; (4) CDC's National Tuberculosis
Surveillance System and Molecular Surveillance; (5) Tuberculosis
Epidemiologic Studies Consortium III; (6) Think. Test. Treat TB
Campaign; (7) Laboratory Developed Tests Workgroup Update; and (8) Drug
[[Page 83689]]
Shortage Workgroup Update. Agenda items are subject to change as
priorities dictate.
Public Participation
Written Public Comment: Members of the public are welcome to submit
written comments in advance of the meeting. Written comments must be
submitted by emailing [email protected] with subject line ``ACET
December 2024 Public Comment Registration'' by November 26, 2024.
Oral Public Comment: Individuals who would like to make an oral
comment during the public comment period must register by emailing
[email protected] with subject line ``ACET December 2024 Public
Comment Registration'' by November 26, 2024. The public comment period
is on December 4, 2024, at 10:15 a.m., EST.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-23885 Filed 10-16-24; 8:45 am]
BILLING CODE 4163-18-P